Fertility Test Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Ovulation Product Kits, Fertility Monitors, Men Fertility Testing Kits, Others), By Application (Female Fertility Testing, Male Fertility Testing), By Mode Of Purchase (Prescription Based, Non-Prescription Based), By End-User (Homecare Setting, Hospitals And Fertility Clinics), And By Geography - Forecasts From 2022 To 2027

Published:  Apr 2022 Report Code: KSI061611911 Pages: 124

The fertility test market is expected to grow at a compound annual growth rate of 5.79% over the forecast period to reach a market size of US$739.616 million in 2027, from US$498.756 million in 2020.


Fertility Testing is a process through which males and females are made aware of their reproductive health that helps them to detect ovulation and to diagnose infertility. This procedure aids in planning pregnancy and helps doctors diagnose the cause of infertility as well.

Market Trend

The growing age of the population and the declining fertility rate is expected to be the primary driver for the market. This is because fertility testing can be considered a safe option to detect pregnancy or ovulation and infertility for people trying to get pregnant at high ages. Besides that, the growing prevalence of PCOS and PCOD among females is considered as another major factor to drive up the fertility test market. Today technology is thriving, and the easy-to-use fertility monitors and kits are in wide demand in the fertility test market, thus constituting a vital growth factor for the fertility test market. Also, In the past few years, fertility tourism has surged significantly, holding an opportunity for the fertility test market to grow at a notable rate in the coming years.

Another considerable contribution to this market is the growing self-health awareness among women. Government and authorities at times set up campaigns and awareness programs to provide the required self-health literacy to women in both developed and developing nations. With the increased awareness, the demand for fertility testing is projected to increase in the coming years.

Although the market includes several growth opportunities, one of the major restraints is that these tests, at times, can generate false results that can hamper the market growth in the future.

Growth Factors

  • Declining Birth Rate and Growing Age of First Time Pregnancies:

The decline in fertility rates in the major countries around the globe has become a serious concern. The birth rate of 2.1 is considered as an ideal rate for a country to naturally replace its population. As reported by World Economic Forum, the United States’ most recent survey showed that its birth rate has been on a continuous decline for the past six years, and its current rate is at 1.6. The report also showed that the birth rate in China and Japan stands at 1.3 while that in Russia, Brazil, and Bangladesh stands at 1.6, 1.8, and 1.7. 

One of the major reasons behind this is the growing age of the population which has simultaneously contributed to the increasing age of first-time pregnancies. According to World Bank, the old-age dependency ratio has increased significantly over the past few decades, and in 2020 it stood at 14.296%. This is expected to be a significant driver of the market as fertility tests can be considered as a safe option to detect the early signs of ovulation and infertility among the high age population.

  • Rising PCOS among the females:

PCOS is one of the major rising causes of infertility among females. PCOS or Polycystic Ovary Syndrome is a hormonal disorder that causes enlarged ovaries and small cysts on the outer edges due to which the ovaries fail to release the eggs, which hampers the menstrual cycle and thereby increases the chances of infertility among women. According to the Centers for Disease Control and Prevention, PCOS affects around 6%-12% (around 5 million) of American women. Since fertility tests can contribute as a primary source of getting information regarding ovulation and infertility, the prevalence of PCOS is directly related to the high demand for fertility tests in the coming years.

  • Fertility Tourism:

Fertility Tourism or cross-border reproductive care or tourism is traveling from one country to another to overcome fertility issues and get fertility treatment. This practice has become popular in the past few decades owing to the factors like strict regulations in domestic countries, better treatment facilities in foreign countries, etc. To work on infertility issues and conceiving problems, fertility tourism involves a high scale application of fertility tests, which can positively impact its market in the forecasted period.


  • False Results:

Although the Fertility tests help to get the required information about fertility and ovulation, at times, these tests can detect false results as well. This problem generally arises in the home urine test kits. There can be several causes, like user error, chemical pregnancy, fertility medications, and recent pregnancies, that may leave behind hCG in the bodies. These factors can contribute to the high probability of false result generation, which can hamper market growth.

Impact of COVID-19 Pandemic on the Fertility Test Market:

The outburst of the COVID pandemic around the globe severely hampered the fertility test market majorly because of less access to non-COVID healthcare facilities. The factors like lockdown, curfew, and the fear of disease restricted the outer movement of the people, and this concern increased significantly for the pregnant ladies during the pandemic. 

Fertility Test Market Scope:

Report Metric Details
 Market size value in 2020  US$498.756 million
 Market size value in 2027  US$739.616 million 
 Growth Rate  CAGR of 5.79% from 2020 to 2027
 Base year  2020
 Forecast period  2022–2027
 Forecast Unit (Value)  USD Million
 Segments covered  Product, Application, Mode of Purchase, End-User, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered Church & Dwight Co., Inc., Geratherm Medical AG, Fertility Focus, Fairhaven Health LLC, bioZhena Corporation, Hilin Life Products, Inc., UEBE Medical GmbH, AdvaCare Pharma, Mankind Pharma Ltd., Modern Fertility
 Customization scope  Free report customization with purchase



  • By Product
    • Ovulation Product Kits
    • Fertility Monitors
    • Men Fertility Testing Kits
    • Others
  • By Application
    • Female fertility testing
    • Male fertility testing
  • By Mode of Purchase
    • Prescription based
    • Non-prescription based
  • By End-User
    • Homecare setting
    • Hospitals and Fertility Clinics
  • By Geography
    • North America
      • USA
      • Canada
      • México
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • U.K.
      • Germany
      • France
      • Others
    • Middle East and Africa
      •  UAE
      • South Africa
      • Israel
      • Saudi Arabia
      • Others
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • Taiwan
      • South Korea
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the fertility test market size by 2027?
A1. The fertility test market is expected to reach a total market size of US$739.616 million in 2027.

Q2. What are the growth prospects for the fertility test market?
A2. The global fertility test market is expected to grow at a CAGR of 5.79% during the forecast period.

Q3. What is the size of the global fertility test market?
A3. Fertility Test Market was valued at US$498.756 million in 2020.

Q4. How is the fertility test market segmented?
A4. The fertility test market has been segmented by product, application, mode of purchase, end-user, and geography.

Q5. What factors are anticipated to drive the fertility test market growth?
A5. The growing age of the population and the declining fertility rate is expected to be the major driver for the fertility test market.

1.1. Market Definition
1.2. Market Segmentation

2.1. Research Data
2.2. Assumptions

3.1. Research Highlights

4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5.1. Introduction
5.2. Ovulation Product Kits
5.3. Fertility Monitors
5.4. Men Fertility Testing Kits
5.5. Others

6.1. Introduction
6.2. Female fertility testing
6.3. Male fertility testing

7.1. Introduction
7.2. Prescription based
7.3. Non-prescription based

8.1. Homecare setting
8.2. Hospitals and Fertility Clinics

9.1.  Introduction
9.2.  North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1.  U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Others
9.5.  Middle East and Africa
9.5.1. UAE
9.5.2. South Africa
9.5.3. Israel
9.5.4. Saudi Arabia
9.5.5. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. Japan
9.6.3. India
9.6.4. Australia
9.6.5. Taiwan
9.6.6. South Korea
9.6.7. Others


10.1. Major Players and Strategy Analysis
10.2.  Emerging Players and Market Lucrativeness
10.3.  Mergers, Acquisitions, Agreements, and Collaborations
10.4.  Vendor Competitiveness Matrix


11.1. Church & Dwight Co., Inc.
11.2. Geratherm Medical AG
11.3. Fertility Focus 
11.4. Fairhaven Health LLC
11.5. bioZhena Corporation
11.6. Hilin Life Products, Inc.
11.7. UEBE Medical GmbH
11.8. AdvaCare Pharma
11.9. Mankind Pharma Ltd.
11.10. Modern Fertility

Church & Dwight Co., Inc.

Geratherm Medical AG

Fertility Focus

Fairhaven Health LLC

bioZhena Corporation

Hilin Life Products, Inc.

UEBE Medical GmbH

AdvaCare Pharma

Mankind Pharma Ltd.

Modern Fertility


Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


We are in compliance with the global privacy laws.

Connect With Us